Lupin launched Clobetasol Propionate in US market

Posted on:13 Oct 2018 11:11:53
Lupin launched Clobetasol Propionate in US market
13 October 2018 Current Affairs: Lupin, Drug firm major, has launched generic Clobetasol Propionate ointment in the U.S. market. This is used to treat inflammation and itching caused by a number of skin conditions. It had earlier received approval for the product from the United States Food and Drug Administration (USFDA), Lupin said in a statement. The company has launched Clobetasol Propionate ointment USP in the strength of 0.05%.
Lupin, Drug firm major, has launched generic Clobetasol Propionate ointment in the U.S. market. This is used to treat inflammation and itching caused by a number of skin conditions. It had earlier received approval for the product from the United States Food and Drug Administration (USFDA), Lupin said in a statement. The company has launched Clobetasol Propionate ointment USP in the strength of 0.05%.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Currentt Affairs 2018 November

19 NOVEMBER
NEWS
18 NOVEMBER
NEWS
17 NOVEMBER
NEWS
16 NOVEMBER
NEWS

Currentt Affairs 2018 October

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS

Currentt Affairs 2018 September

30 SEPTEMBER
NEWS
29 SEPTEMBER
NEWS
28 SEPTEMBER
NEWS
27 SEPTEMBER
NEWS